CD19 and antiphospholipid syndrome: In a preliminary study, patients with SLE and secondary antiphospholipid syndrome (APS) showed depletion of CD3-CD19+ B cells, and their decreasing number correlated with the severity of SLE (Dal Ben et al. 2014).